Cargando…
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better understanding of tumor biology, tissue-agnostic targets have been characterized and explored, which ultimately led to therapeutics with pan-cancer efficacy. To date, five molecular biomarkers have obtained FDA tissu...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for Cancer Research
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390861/ https://www.ncbi.nlm.nih.gov/pubmed/37061987 http://dx.doi.org/10.1158/1078-0432.CCR-23-0090 |